![Jonathan Yingling](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan Yingling
Directeur Technique/Scientifique/R&D chez ARCUS BIOSCIENCES, INC.
Postes actifs de Jonathan Yingling
Sociétés | Poste | Début | Fin |
---|---|---|---|
ARCUS BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/01/2020 | - |
Historique de carrière de Jonathan Yingling
Anciens postes connus de Jonathan Yingling
Sociétés | Poste | Début | Fin |
---|---|---|---|
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Directeur Technique/Scientifique/R&D | 01/01/2018 | 31/01/2020 |
Corporate Officer/Principal | 06/02/2017 | 01/01/2018 | |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/06/2013 | 01/10/2015 |
DNIB UNWIND INC | Directeur Technique/Scientifique/R&D | 16/12/2015 | - |
Formation de Jonathan Yingling
Duke University School of Medicine | Doctorate Degree |
The College of William & Mary | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ARCUS BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
DNIB Unwind, Inc.
![]() DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Bourse
- Insiders
- Jonathan Yingling
- Expérience